Bioactive hydrocolloid dressings that combine exudate management with cell-regulatory functions are attractive for skin wound repair. In this study, a composite hydrocolloid dressing (MgBG/CMC) was fabricated and evaluated for its physicochemical properties and wound-healing performance. MgBG incorporation enhanced the fluid absorption capacity of the CMC matrix. In vivo , MgBG/CMC was associated with faster wound closure in a New Zealand white rabbit ear acute wound model, whereas its additional benefit over CMC alone was limited in a glucocorticoid-impaired chronic wound model established in Sprague-Dawley rats and in subsequent exploratory hypertrophic-scar assessment. In vitro , MgBG extracts selectively increased HaCaT keratinocyte viability while showing minimal effects on dermal fibroblast viability and endothelial tube formation. These results suggest that the current MgBG/CMC formulation may be more suitable for acute wound management than for the impaired-healing and scar-related conditions evaluated in this study, an observation consistent with improved fluid absorption and enhanced keratinocyte responses; however, the relative contributions of ionic dissolution, matrix properties, and other factors remain to be elucidated. Overall, this study presents a simple bioactive hydrocolloid dressing strategy for acute wound management and provides insights into the application boundaries of the current MgBG formulation.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: